Status: current, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554214018 | Trilaciclib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4554215017 | Trilaciclib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trilaciclib | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Trilaciclib | Is a | Protein kinase inhibitor | true | Inferred relationship | Some | ||
| Trilaciclib | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Trilaciclib | Has disposition | Protein kinase inhibitor | true | Inferred relationship | Some | ||
| Trilaciclib | Is a | Pyrrole | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trilaciclib dihydrochloride | Is modification of | True | Trilaciclib | Inferred relationship | Some | |
| Trilaciclib only product | Has active ingredient | True | Trilaciclib | Inferred relationship | Some | 1 |
| Trilaciclib-containing product in parenteral dose form | Has active ingredient | True | Trilaciclib | Inferred relationship | Some | 1 |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg lyophilised powder for solution for injection vial | Has BoSS | False | Trilaciclib | Inferred relationship | Some | 1 |
| Trilaciclib-containing product | Has active ingredient | True | Trilaciclib | Inferred relationship | Some | 1 |
| Trilaciclib only product in parenteral dose form | Has active ingredient | True | Trilaciclib | Inferred relationship | Some | 1 |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has BoSS | True | Trilaciclib | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR